[PDF] Top 20 Continuation treatment of major depressive disorder: is there a case for duloxetine?
Has 10000 "Continuation treatment of major depressive disorder: is there a case for duloxetine?" found on our website. Below are the top 20 most common "Continuation treatment of major depressive disorder: is there a case for duloxetine?".
Continuation treatment of major depressive disorder: is there a case for duloxetine?
... of treatment in this phase was 305 days with a range of 4 to 623 ...of duloxetine over extended ...the continuation phase of treatment 21 patients ...discontinued treatment due to ... See full document
13
Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
... index case in claims studies. Data on MDD severity, treatment outcomes, patient preferences, and health plan restrictions were also unavailable; hence, comorbidities and health care resource utilization ... See full document
10
Effectiveness and cost effectiveness of transmural collaborative care with consultation letter (TCCCL) and duloxetine for major depressive disorder (MDD) and (sub)chronic pain in collaboration with primary care: design of a randomized placebo controlled multi Centre trial: TCC:PAINDIP
... solving treatment (PST), both effective in the treatment of depression ...the treatment if pain and depres- sion coexist, as well as selective serotonin and noradre- nalin reuptake inhibitors (SNRIs) ... See full document
14
An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
... vious depressive episode, 2) BPI-SF average pain score (#6 vs ...non-retrievable case report forms, patients for whom administration of the study drug could not be confirmed, and patients who did not meet ... See full document
10
An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
... non-retrievable case report form, patients for whom administration of study drug could not be confirmed, and patients who had no post- baseline ...For treatment group comparisons, propensity scoring, the ... See full document
10
Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine
... complete case basis involving each scan session ...the treatment and control samples, as well as prediction of treatment improvement (with HRSD-17 or HAMA) from baseline functional ... See full document
11
Comparative Effect of Collaborative Care, Pain Medication, and Duloxetine in the Treatment of Major Depressive Disorder and Comorbid (Sub)Chronic Pain : Results of an Exploratory Randomized, Placebo-Controlled, Multicenter Trial (CC:PAINDIP)
... in case of too severe language barrier; dementia; history of renal and liver dysfunction for which treat- ment is needed; uncontrolled hypertension despite treatment for hypertension; suicidal ideation if ... See full document
14
Duloxetine in the treatment of major depressive disorder: an open label study
... of treatment-emergent abnormal labo- ratory values was ...the case of liver enzymes, the incidence of alanine transaminase (ALT) and aspartate transaminase (AST) values greater than or equal to 1, 3, 5, 10, ... See full document
11
Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
... (with duloxetine as the active comparator) in the treatment of depression in the elderly population appropri- ately included an assessment of cognitive ...of treatment on cognitive function, subjects ... See full document
11
Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
... Conclusion: This review indicated the efficacy in the acute treatment of Esc vs Dul varied relying on measurements across the studies. However, the tolerability of Esc was superior to Dul in acute MDD ... See full document
9
Antidepressant medication treatment patterns in Asian patients with major depressive disorder
... to treatment, age and country were factors that were significantly associated with time to ...discontinued treatment significantly earlier than younger patients (hazard ratio [HR] ...discontinued ... See full document
8
Desvenlafaxine in the treatment of major depressive disorder
... Potential advantages for DVS over other SSRIs/SNRIs drugs include the narrow dose range, where the initial dose (50 mg) may prove to be the optimal therapeutic dose, in contrast to venlafaxine where extensive dose ... See full document
10
Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
... label treatment with duloxetine (80 mg/d or 120 ...of duloxetine (60 mg once daily (QD)) in patients aged 55 years and older ...which duloxetine demonstrated significant superiority over pla- ... See full document
10
Major depressive disorder as a nonlinear dynamic system: bimodality in the frequency distribution of depressive symptoms over time
... The current study was intended as a preliminary proof- of-principle study and several limitations should be kept in mind when interpreting the presented results. First, the bimodality pattern we discovered in part might ... See full document
9
Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
... compare treatment outcomes in patients with major depressive disorder treated with duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline for up to 6 ...1,549 major ... See full document
12
Complementary and alternative medicine for the treatment of major depressive disorder
... for treatment of depression, with most trials reporting no better outcomes than experienced by wait- list ...been case reports of infection and tran- sient ... See full document
5
Comparative efficacy of escitalopram in the treatment of major depressive disorder
... Results: The search initially identified 24 eligible studies, of which 12 (six pooled analysis and six meta-analysis studies) met the criteria for review. The pooled and meta-analysis studies with citalopram showed ... See full document
11
Vilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapy
... The medical literature was reviewed for appropriate articles related to vilazodone on PubMed (http://www.ncbi.nlm.nih. gov) using the search term “vilazodone” and EMD 68843, its investigational name. The search was ... See full document
14
Levomilnacipran for the treatment of major depressive disorder: a review
... the treatment of major depressive ...including duloxetine, venlafaxine, and desvenlafaxine, it has greater selectivity for inhibiting norepinephrine reuptake than serotonin ...antidepressant ... See full document
11
Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
... Our results show that different starting doses and titration meth- ods for duloxetine may result in different tolerability profiles. We explored this relationship using individual patient data collected from ... See full document
9
Related subjects